Omnicare Stock Hits New 52-Week High (OCR)

NEW YORK ( TheStreet) -- Omnicare (NYSE: OCR) hit a new 52-week high Thursday as it is currently trading at $50.24, above its previous 52-week high of $50.22 with 155,769 shares traded as of 10:05 a.m. ET. Average volume has been 956,800 shares over the past 30 days.

Omnicare has a market cap of $5.21 billion and is part of the services sector and wholesale industry. Shares are up 37.3% year to date as of the close of trading on Wednesday.

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company operates in two segments, Long-Term Care Group and Specialty Care Group.

• EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Omnicare Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..